Linder S - Search Results

1

The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.

Ueno T, Elmberger G, Weaver TE, Toi M, Linder S. Ueno T, et al. Among authors: linder s. Lab Invest. 2008 Mar;88(3):256-63. doi: 10.1038/labinvest.3700718. Epub 2008 Jan 14. Lab Invest. 2008. PMID: 18195689 Free article.

2

Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas.

Chuman Y, Bergman A, Ueno T, Saito S, Sakaguchi K, Alaiya AA, Franzén B, Bergman T, Arnott D, Auer G, Appella E, Jörnvall H, Linder S. Chuman Y, et al. Among authors: linder s. FEBS Lett. 1999 Nov 26;462(1-2):129-34. doi: 10.1016/s0014-5793(99)01493-3. FEBS Lett. 1999. PMID: 10580105 Free article.

3

Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner.

Mandic A, Viktorsson K, Molin M, Akusjärvi G, Eguchi H, Hayashi SI, Toi M, Hansson J, Linder S, Shoshan MC. Mandic A, et al. Among authors: linder s. Mol Cell Biol. 2001 Jun;21(11):3684-91. doi: 10.1128/MCB.21.11.3684-3691.2001. Mol Cell Biol. 2001. PMID: 11340162 Free PMC article.

4

A novel high-through-put assay for screening of pro-apoptotic drugs.

Hägg M, Bivén K, Ueno T, Rydlander L, Björklund P, Wiman KG, Shoshan M, Linder S. Hägg M, et al. Among authors: linder s. Invest New Drugs. 2002 Aug;20(3):253-9. doi: 10.1023/a:1016249728664. Invest New Drugs. 2002. PMID: 12201488

5

Measurement of an apoptotic product in the sera of breast cancer patients.

Ueno T, Toi M, Bivén K, Bando H, Ogawa T, Linder S. Ueno T, et al. Among authors: linder s. Eur J Cancer. 2003 Apr;39(6):769-74. doi: 10.1016/s0959-8049(02)00865-1. Eur J Cancer. 2003. PMID: 12651202

6

Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.

Ueno T, Linder S, Elmberger G. Ueno T, et al. Among authors: linder s. Br J Cancer. 2003 Apr 22;88(8):1229-33. doi: 10.1038/sj.bjc.6600879. Br J Cancer. 2003. PMID: 12698189 Free PMC article.

7

A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera.

Bivén K, Erdal H, Hägg M, Ueno T, Zhou R, Lynch M, Rowley B, Wood J, Zhang C, Toi M, Shoshan MC, Linder S. Bivén K, et al. Among authors: linder s. Apoptosis. 2003 Jun;8(3):263-8. doi: 10.1023/a:1023672805949. Apoptosis. 2003. PMID: 12766486

8

Processing of pulmonary surfactant protein B by napsin and cathepsin H.

Ueno T, Linder S, Na CL, Rice WR, Johansson J, Weaver TE. Ueno T, et al. Among authors: linder s. J Biol Chem. 2004 Apr 16;279(16):16178-84. doi: 10.1074/jbc.M312029200. Epub 2004 Feb 6. J Biol Chem. 2004. PMID: 14766755 Free article.

9

A close association between alteration in growth kinetics by neoadjuvant chemotherapy and survival outcome in primary breast cancer.

Takada M, Kataoka A, Toi M, Bando H, Toyama K, Horiguchi S, Ueno T, Linder S, Saji S, Hayashi Y, Funata N, Kinoshita J, Murakami S, Ohono S. Takada M, et al. Among authors: linder s. Int J Oncol. 2004 Aug;25(2):397-405. Int J Oncol. 2004. PMID: 15254737

10

Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker.

Linder S, Havelka AM, Ueno T, Shoshan MC. Linder S, et al. Cancer Lett. 2004 Oct 8;214(1):1-9. doi: 10.1016/j.canlet.2004.06.032. Cancer Lett. 2004. PMID: 15331168 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

701 results

Search Page

Filters